Skip to main content
HOLISTA COLLTECH LIMITED logo

HOLISTA COLLTECH LIMITED — Investor Relations & Filings

Ticker · HCT ISIN · AU000000HCT4 ASX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2020-03-03 Capital/Financing Update
Country AU Australia
Listing ASX HCT

About HOLISTA COLLTECH LIMITED

https://www.holistaco.com

Holista CollTech Limited is a research-driven company focused on the development and commercialization of natural health products and ingredients. The company specializes in three primary areas: ovine collagen, food-grade ingredients, and infection control solutions. Its proprietary collagen extraction technology produces high-quality, disease-free ovine collagen for the cosmetic and medical industries. In the food sector, the company develops low-glycemic index (GI) formulations for staple foods like bread, noodles, and pasta to address global health concerns such as diabetes and obesity. Additionally, Holista CollTech offers natural sanitization products based on plant-derived active ingredients. The company aims to provide scientifically validated solutions that enhance wellness and food quality through sustainable and natural processes.

Recent filings

Filing Released Lang Actions
S708 Cleansing Notice 1 page 52.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement titled 'NOTICE PURSUANT TO SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001 S708A CLEANSING NOTICE'. It discusses the completion of a share issue (10,625,000 Ordinary Fully Paid Shares) under a Controlled Placement Agreement and compliance with relevant sections of the Corporations Act. The content focuses on share issuance and regulatory compliance related to capital raising. The document length is short (1285 characters) and it is an announcement rather than a detailed report. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2020-03-03 English
Letter of confirmation towards global distribution rights 3 pages 69.5KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 3 March 2020 from Holista CollTech Limited. It provides an update on the NatShield™ sanitiser product, including details about a letter of confirmation for global distribution rights, order quantities, bottling capacity, and market expansion. The content focuses on business updates and operational progress rather than financial results, regulatory filings, or detailed financial statements. There is no indication that this is a financial report, earnings release, or management discussion. It is a corporate announcement about product distribution and operational updates. Therefore, the most appropriate classification is a Capital/Financing Update (CAP) as it relates to distribution rights and business expansion, which falls under financing or capital structure updates rather than other categories like earnings or annual reports.
2020-03-02 English
Appendix 4E Preliminary Final Report 21 pages 559.5KB
Annual Report Classification · 95% confidence The document is titled 'APPENDIX 4E Preliminary Final Report 31 December 2019' for Holista Colltech Limited. Appendix 4E is a regulatory filing used in Australia for preliminary final reports, which are essentially preliminary annual financial reports. The document contains detailed financial statements such as consolidated statement of profit or loss, financial position, changes in equity, cash flows, and notes. It also includes a comprehensive company update and operational review for the fiscal year ending 31 December 2019. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a full financial report rather than a brief announcement or certification. Therefore, this document corresponds to an Annual Report type filing, specifically a preliminary final report which is equivalent to an annual report (10-K) in the Australian context.
2020-02-27 English
Initial Director's Interest Notice 2 pages 101.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares held directly and indirectly, and notes the director's appointment date. The content focuses on disclosure of personal shareholdings and interests of a company director, which aligns with insider trading or director dealings disclosures. The document length is 2250 characters, indicating it is a short notice rather than a full report. This matches the definition of 'Director's Dealing' filings, which report personal share transactions or interests by company directors and executives. Therefore, the correct classification is DIRS.
2020-02-26 English
Dr Arthur Martin joins Scientific Advisory Board 3 pages 79.8KB
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of Dr. Arthur Martin to the Scientific Advisory Board of Holista CollTech Limited. It contains no financial data, no regulatory filing references, no voting results, no financial statements, and no mention of any report publication or filing. It is a corporate announcement about management/scientific advisory board changes. Therefore, it fits best under Board/Management Information (MANG). The document length is 6678 characters, which is sufficient for a detailed announcement but does not contain financial or regulatory report content.
2020-02-26 English
Retraction of Statements and Clarification 5 pages 94.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 25 February 2020 from Holista CollTech Limited. It primarily addresses the retraction of previous statements and clarifications regarding product development and regulatory approvals. The content focuses on correcting and clarifying prior announcements and presentations, rather than presenting financial data, management changes, or detailed financial results. There is no indication of financial statements, earnings data, or management reports. The document is a regulatory announcement clarifying and retracting prior statements to comply with disclosure standards. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2020-02-24 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.